Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P15
Within normal range
vs 5Y Ago
-6.3x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | -31.79% |
| 2023 | 214.83% |
| 2022 | -68.09% |
| 2021 | 477.92% |
| 2020 | -58.34% |
| 2019 | 5.03% |
| 2018 | 47.13% |
| 2017 | -30.92% |
| 2016 | 16.10% |
| 2015 | 16.28% |